Novoron Bioscience Competitors and Similar CompaniesClear all
CTI BioPharma's competitors and similar companies include Palatin Technologies.
 CTI BioPharma CTI BioPharma is a biopharmaceutical company focused on the acquisition, development and commercialization of targeted therapies covering a spectrum of blood-related cancers that offer a benefit to patients and healthcare providers. |  Palatin Technologies Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases. | |
Founding Date | Founding Date 1992 | Founding Date 1986 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ Köln, DE | Locations East Windsor, US HQ |
Employees | Employees 2546% decrease | Employees 185% decrease |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 22.5 m |
Financial | ||
Net income | Net income ($93m) (FY, 2022) | Net income ($17.3m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 105m | Total funding raised $ 104.2m |
For sources of this data, please see the company profile
View Company Profiles
Palatin Technologies
HQ
East Windsor, US
Employees
18↓ 5% decrease
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
View company